MA42618A - Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés - Google Patents
Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylésInfo
- Publication number
- MA42618A MA42618A MA042618A MA42618A MA42618A MA 42618 A MA42618 A MA 42618A MA 042618 A MA042618 A MA 042618A MA 42618 A MA42618 A MA 42618A MA 42618 A MA42618 A MA 42618A
- Authority
- MA
- Morocco
- Prior art keywords
- fatty acids
- cétyl
- preparation
- system used
- cetyl
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title 2
- 229930195729 fatty acid Natural products 0.000 title 2
- 239000000194 fatty acid Substances 0.000 title 2
- -1 CETYL FATTY ACIDS Chemical class 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/08—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with fatty acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A003130A ITUB20153130A1 (it) | 2015-08-14 | 2015-08-14 | Acidi grassi cetilati, impianto per la loro preparazione e relativo uso |
| PCT/IB2016/054788 WO2017029580A1 (fr) | 2015-08-14 | 2016-08-09 | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA42618A true MA42618A (fr) | 2021-04-07 |
| MA42618B1 MA42618B1 (fr) | 2021-10-29 |
Family
ID=55069943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42618A MA42618B1 (fr) | 2015-08-14 | 2016-08-09 | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10597608B2 (fr) |
| EP (2) | EP3334705B1 (fr) |
| CN (1) | CN108137472B (fr) |
| CA (1) | CA2995314C (fr) |
| CY (1) | CY1124710T1 (fr) |
| DK (1) | DK3334705T3 (fr) |
| ES (1) | ES2897903T3 (fr) |
| HK (1) | HK1254896A1 (fr) |
| HR (1) | HRP20211702T1 (fr) |
| HU (1) | HUE056361T2 (fr) |
| IL (2) | IL294422B1 (fr) |
| IT (1) | ITUB20153130A1 (fr) |
| LT (1) | LT3334705T (fr) |
| MA (1) | MA42618B1 (fr) |
| MD (1) | MD3334705T2 (fr) |
| MY (1) | MY182324A (fr) |
| PL (1) | PL3334705T3 (fr) |
| PT (1) | PT3334705T (fr) |
| RS (1) | RS62429B1 (fr) |
| RU (1) | RU2756515C2 (fr) |
| SI (1) | SI3334705T1 (fr) |
| WO (1) | WO2017029580A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| IT201900007329A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT202100030170A1 (it) | 2021-11-29 | 2023-05-29 | Pharmanutra S P A | Cerotto transdermico, e uso di detto cerotto in un metodo di trattamento di un disturbo, o disordine, o patologia, di un tendine |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049824A (en) * | 1976-05-03 | 1977-09-20 | Harry Weldon Diehl | Cetyl myristoleate |
| DE3468433D1 (en) * | 1983-05-19 | 1988-02-11 | Asahi Denka Kogyo Kk | Reaction method for transesterifying fats and oils |
| GB2233227A (en) * | 1989-06-09 | 1991-01-09 | Paul Eldred Buckenham | Zinc compositions for treatment of foot odour |
| CN1197688A (zh) * | 1997-04-29 | 1998-11-04 | 德国泰克萨科股份公司 | 在反应塔中物质的化学反应方法 |
| US5898077A (en) * | 1997-10-07 | 1999-04-27 | Matsumoto Yushi-Seiyaku Co., Ltd. | Process for preparation of an ester |
| WO2003018731A1 (fr) * | 1998-11-23 | 2003-03-06 | Dianne Cadwallader | Synthese de fragments alkyle a chaine longue a liaison ester |
| AU775941B2 (en) * | 2000-05-12 | 2004-08-19 | Lypanosys Pte Limited | Treating irritable bowel syndrome or disease |
| NZ522434A (en) * | 2001-05-11 | 2005-09-30 | Meracol Corp Ltd | Treating eczema and/or psoriasis |
| DE10251984A1 (de) * | 2002-11-08 | 2004-05-19 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung eines Esters |
| TWI324592B (en) * | 2002-11-28 | 2010-05-11 | Sulzer Chemtech Ag | A method for the esterification of a fatty acid |
| US7612111B2 (en) * | 2003-03-20 | 2009-11-03 | Imagenetix, Inc. | Esterified fatty acid composition |
| RU2228745C1 (ru) * | 2003-04-16 | 2004-05-20 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Адаптогенный лекарственный перепарат для перорального применения |
| US8815282B1 (en) * | 2005-07-15 | 2014-08-26 | Edward C. Leonard | Commercial method for production of room temperature-liquid cetyl myristoleate |
| US7276621B2 (en) * | 2005-08-12 | 2007-10-02 | Eastman Chemical Company | Production of di-(2-ethylhexyl) terephthalate |
| EP2205709A1 (fr) * | 2007-10-30 | 2010-07-14 | Bayer Technology Services GmbH | Procédé d'estérification à catalyse hétérogène d'acides gras |
| US8394759B2 (en) * | 2008-11-21 | 2013-03-12 | Cymbiotics, Inc. | Transdermal delivery of medicaments with combinations of cetylated fatty ester penetrant complexes |
| US20110039928A1 (en) * | 2009-08-13 | 2011-02-17 | Golini Jeffrey M | Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition |
| WO2011044381A1 (fr) * | 2009-10-07 | 2011-04-14 | Inflasoothe, Inc. | Composition, système et procédé pour soulager la douleur |
| EP2543364A1 (fr) * | 2010-10-14 | 2013-01-09 | Deva Holding Anonim Sirketi | Formulations de cetyl myristate et/ou cetyl palmitate |
| CN103880656A (zh) * | 2012-12-24 | 2014-06-25 | 青岛帅王油脂化学有限公司 | 一种脂肪酸酯化的方法 |
-
2015
- 2015-08-14 IT ITUB2015A003130A patent/ITUB20153130A1/it unknown
-
2016
- 2016-08-09 LT LTEPPCT/IB2016/054788T patent/LT3334705T/lt unknown
- 2016-08-09 ES ES16767360T patent/ES2897903T3/es active Active
- 2016-08-09 PL PL16767360T patent/PL3334705T3/pl unknown
- 2016-08-09 MY MYPI2018700478A patent/MY182324A/en unknown
- 2016-08-09 HR HRP20211702TT patent/HRP20211702T1/hr unknown
- 2016-08-09 MA MA42618A patent/MA42618B1/fr unknown
- 2016-08-09 IL IL294422A patent/IL294422B1/en unknown
- 2016-08-09 DK DK16767360.7T patent/DK3334705T3/da active
- 2016-08-09 IL IL257143A patent/IL257143B/en unknown
- 2016-08-09 CN CN201680047292.1A patent/CN108137472B/zh active Active
- 2016-08-09 WO PCT/IB2016/054788 patent/WO2017029580A1/fr active Application Filing
- 2016-08-09 HU HUE16767360A patent/HUE056361T2/hu unknown
- 2016-08-09 CA CA2995314A patent/CA2995314C/fr active Active
- 2016-08-09 EP EP16767360.7A patent/EP3334705B1/fr active Active
- 2016-08-09 SI SI201631348T patent/SI3334705T1/sl unknown
- 2016-08-09 MD MDE20180613T patent/MD3334705T2/ro unknown
- 2016-08-09 EP EP21189422.5A patent/EP3943478A1/fr active Pending
- 2016-08-09 RS RS20211241A patent/RS62429B1/sr unknown
- 2016-08-09 PT PT167673607T patent/PT3334705T/pt unknown
- 2016-08-09 RU RU2018108294A patent/RU2756515C2/ru active
- 2016-08-09 US US15/750,485 patent/US10597608B2/en active Active
-
2018
- 2018-11-01 HK HK18113995.8A patent/HK1254896A1/zh unknown
-
2020
- 2020-02-12 US US16/789,289 patent/US11186536B2/en active Active
-
2021
- 2021-11-09 CY CY20211100973T patent/CY1124710T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3334705T3 (pl) | 2022-01-10 |
| CN108137472B (zh) | 2021-08-03 |
| ITUB20153130A1 (it) | 2017-02-14 |
| CN108137472A (zh) | 2018-06-08 |
| IL294422A (en) | 2022-08-01 |
| CA2995314C (fr) | 2024-01-09 |
| RS62429B1 (sr) | 2021-11-30 |
| US20190016991A1 (en) | 2019-01-17 |
| MY182324A (en) | 2021-01-19 |
| RU2756515C2 (ru) | 2021-10-01 |
| EP3334705B1 (fr) | 2021-09-15 |
| SI3334705T1 (sl) | 2021-12-31 |
| EP3334705A1 (fr) | 2018-06-20 |
| EP3943478A1 (fr) | 2022-01-26 |
| US11186536B2 (en) | 2021-11-30 |
| IL257143B (en) | 2022-08-01 |
| IL294422B1 (en) | 2024-03-01 |
| CY1124710T1 (el) | 2022-07-22 |
| CA2995314A1 (fr) | 2017-02-23 |
| US10597608B2 (en) | 2020-03-24 |
| LT3334705T (lt) | 2021-12-10 |
| PT3334705T (pt) | 2021-11-04 |
| MA42618B1 (fr) | 2021-10-29 |
| WO2017029580A1 (fr) | 2017-02-23 |
| HUE056361T2 (hu) | 2022-02-28 |
| DK3334705T3 (da) | 2021-11-01 |
| RU2018108294A (ru) | 2019-09-16 |
| IL257143A (en) | 2018-03-29 |
| HK1254896A1 (zh) | 2019-08-02 |
| RU2018108294A3 (fr) | 2020-05-18 |
| HRP20211702T1 (hr) | 2022-02-04 |
| ES2897903T3 (es) | 2022-03-03 |
| US20200181530A1 (en) | 2020-06-11 |
| MD3334705T2 (ro) | 2022-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50482A (fr) | Dérivés cyclisés de sulfamoylarylamide et leur utilisation comme médicaments pour le traitement de l'hépatite b | |
| DK3273942T3 (da) | Mikronåleplaster til indgivelse af en aktiv bestanddel til huden | |
| MA43365A (fr) | Anticorps anti-dr5 et procédés d'utilisation de ceux-ci | |
| IL250239B (en) | A method for the preparation of (4)-4-(s4-cyano-2-methoxyphenyl)-5-ethoxy-8,2-dimethyl-4,1-dihydro-6,1-naphthyridine-3-carboxamide and its purification for use as an active pharmaceutical ingredient | |
| HK1247143A1 (zh) | 用於製備並施用血液組分的儀器和方法 | |
| ES2700859T8 (es) | Máquina y procedimiento para la preparación automática de sustancias de aplicación intravenosa | |
| EP3223693A4 (fr) | Systèmes et procédés non invasifs de détection de dépression d'étalement cortical pour la détection et l'évaluation de lésions et commotions cérébrales | |
| EP3110946A4 (fr) | Procédés et compositions destinées à induire la différentiation de progéniteurs des adipocytes bruns humains | |
| EP3131465A4 (fr) | Système et procédé pour une émission améliorée de la lumière vers et depuis des sujets | |
| MA42618A (fr) | Acides gras cétylés, système utilisé pour leur préparation et utilisation desdits acides gras cétylés | |
| FR3028963B1 (fr) | Systeme de protection pour afficheur, notamment tete haute, et afficheur associe | |
| MA44056A (fr) | Anticorps anti-rispéridone et leur utilisation | |
| EP3102585A4 (fr) | Esters d'acide boronique et leurs formulations pharmaceutiques | |
| CY1121105T1 (el) | Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv | |
| PT3509413T (pt) | Sistemas de colheita de canábis medicinal | |
| MA42964A (fr) | Préparation pharmaceutique anti-vieillissement | |
| EP3384442A4 (fr) | Système et procédé destinés à l'identification au site de soins de lacunes dans les soins | |
| MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
| EP3253372B8 (fr) | Préparation d'une émulsion huile dans l'eau pour formulations pharmaceutiques stabilisées par un polymère | |
| FR3007611B1 (fr) | Procede d'elaboration securisee de preparations medicamenteuses, ainsi que systeme d'imagerie de mise en oeuvre | |
| BR112016018077A2 (pt) | inibidor de proteína de transferência de éster colesterílico (composto a), composições farmacêuticas compreendendo o mesmo, método para preparação das referidas composições e uso do composto a | |
| SG11201802528PA (en) | Syringe device for communicating two types of substances to each other and method thereof | |
| DK3471797T3 (da) | Engangssystem til flere formål og tilknyttet sprøjte | |
| DK3247394T3 (da) | Farmaceutisk formulering omfattende anti-egfr-antistof | |
| MA41912A (fr) | Esters de glycosaminoglycane, procédés pour leur préparation et leur utilisation dans des formulations à usage ophtalmique |